With an in-depth experience in research and clinical development of vaccines, in both private and non-private organizations, our executive management team evaluates potential opportunities, develops and implements strategies and guides our technical and scientific staff to achieve the mission and goals of Hilleman Laboratories.
Focused on promoting an innovative health solutions-led science culture and developing a robust pipeline of vaccine research projects, our executive management is responsible for implementing and overseeing the research programmes in an efficient and result oriented manner.
DR. DAVINDER GILL
Chief Executive Officer
Dr. Davinder Gill has served as the Chief Executive Officer at Hilleman Laboratories since 2012. Dr. Gill comes with two decades of R&D and business experience in Global Pharma and Biotech companies. At Hilleman Labs, Dr. Gill is responsible for Company Strategy, Product Development, Fund Raising and Public Affairs.
Dr. Gill started his career in 1998 at Millennium Pharmaceuticals in Cambridge, Massachusetts in the area of Biotherapeutics. In 2003, he moved to Wyeth, Collegeville, Pennsylvania where he served in roles of increasing responsibility as Vice President of Biological Technologies. At Wyeth, Dr. Gill was instrumental in creating and leading first-of-their-kind R&D Laboratories in Ireland and Scotland in collaboration with local governments. After the acquisition of Wyeth in 2009, Dr. Gill served as Vice President and Head, Global Biotherapeutics at Pfizer, New York where he successfully led an international team and was a member of Pfizer CEO Council. In 2012, Dr. Gill was appointed CEO at Hilleman Laboratories.
Dr. Gill holds a Ph.D in Chemical Engineering from University of Houston, Texas and is an alumnus of the Indian Institute of Technology. He completed a Cancer Research Institute (New York) Fellowship at the Massachusetts General Hospital/Harvard Medical School in Boston, Massachusetts.
In addition to his role as CEO at Hilleman Labs, Dr. Gill is also a member of The Wellcome Trust (London, UK) Affordable Healthcare Initiative as well as the National Committee on Public Health, Confederation of Indian Industry (New Delhi, India).
Dr. Gill is the founder of a private charity, Amkar Trust.
MS. SWATI YADAV
VICE PRESIDENT – STRATEGIC HRM & BUSINESS SUPPORT
Swati is a Global Human Resource Leader with 18 years of work experience in Strategic HRM.
Swati has worked towards building effective Transformation, Change Management, Leadership and Succession Management. In addition, her work has included Learning & Development, advancing diversity and inclusion initiatives and developing innovative talent management strategies.
Prior to Hilleman Labs, Swati led HR function across Industries and sectors including Pharmaceuticals, Telecommunication, Manufacturing, Consulting and Social Sector in emerging and developed markets in multicultural environment.
Swati is a Post Graduate and Merit Holder in MBA from Xavier Institute of Management, Bhubaneswar. Swati holds graduate degrees in Law and Commerce. Swati is also a certified Career-Life Coach.
MR. SOURABH SOBTI
Vice President – Vaccine Strategy and Implementations
Sourabh Sobti is Vice President -Vaccine Strategy and Implementation at Hilleman Laboratories. Sourabh has over 12 years of experience in consulting, product development and commercialization of vaccines and pharmaceutical products.
Prior to joining Hilleman Labs, Sourabh worked as Senior Manager in Global Markets team at Clinton Health Access Initiative(CHAI) where he managed strategic market access projects at vaccine and pharmaceutical manufacturers in India and South-East Asia to ensure sustainable access to health commodities in low and middle-income countries. Sourabh led due diligence projects for key vaccines, malaria, and oncology products; negotiated pricing agreements to streamline supply and accelerate introduction of quality assured drugs and vaccines.
Prior to CHAI, Sourabh worked as a Management Consultant focusing on Life Sciences sector and was advising pharma and biotech companies on portfolio prioritization, market entry strategy, operating model re-design and business process management projects. Sourabh started his career working as a cell culture process development scientist at UCB and AveciaBiologics in UK.
Sourabh obtained his Masters in Science in Biochemical Engineering from University College London and Bachelors of Sciences (Honors) from Northumbria University at Newcastle UK.
MS. SAROJ AGARWAL
VICE PRESIDENT – FINANCE & COMPANY SECRETARY
Saroj is a Finance Leader with over 18 years of professional experience across industries including 9 years of experience as CFO & CS/ Head Finance across Startups, Listed Company with multiple manufacturing setups.
Prior to Hilleman Labs, Saroj has led Finance function across Industries including Food & Beverage, Print Media, Information Technology and Consulting. She brings rich expertise in Strategic Partnering & Planning, Finance, Accounts, Treasury, Budgetary Planning & Controlling, Financial Reporting, Costing, Internal Audit, Taxation, Company Law, and SEBI Regulations & Corporate Governance. Saroj has been instrumental in setting up organizations and building the foundational pillars in terms structure, team, systems and processes to help organizations scale and sustain growth.
Saroj is a Chartered Accountant, Cost Accountant and Company Secretary and Rank – holder in CA and CS. She is an Associate Member of the Institute of Chartered Accountants of India and Institute of Company Secretaries of India.
Saroj holds a B.com (Hons.) Degree from University of Calcutta.